BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Contact

Corporate Headquarters

4131 Parklake Avenue, Suite 225 Raleigh, NC 27612

Tel: 919-582-9050 Toll-free: 1-877-579-4578 Fax: 919-582-9051

Asterisks denote required fields

Recent BDSI News

April 20, 2021

RALEIGH, N.C. , April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021

Read more
March 10, 2021

Total Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million Record Level Profitability with Net Income of $25.7 Million , Full-Year EBITDA Margin of 26% and Operating Cash Generation of $25 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today

Read more
February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full

Read more
More news

Upcoming Events

BDSI First Quarter 2021 Financial Results Call and Webcast May 6, 2021 8:30 AM EDT

Stay Connected

Stay up to date on the latest news

Get started now
April 22, 2021BDSI $3.42/ - 0%
Data provided by Nasdaq. Minimum 15 minutes delayed.